Members of the Council of German BioRegions
|Bioregion||BMD GmbH Life Sciences Agency Sachsen-Anhalt|
|Contact Person||Dr. Michael Täger|
|R&D-Focus||Medical Biotechnology and biopharmaceuticals: recombinant proteins, protein engineering, protein biochemistry, molecular biology, biopharmaceutical development and production of veterinary and human vaccines and pharmaceuticals, development of new therapies for autoimmune and neurodegenerative diseases, immunodiagnostics, clinical studies
Plant biotechnology and plant breeding: plant genetics, crop plant research, marker-assisted breeding, biopharming, energy plant research
Industrial biotechnology: industrial use of renewable ressources, sustainable production of biopolymers and related products, development of novel technical enzymes, microalgae as ressources of biomass and high-value products
|Selected Regional /Thematic Clusters/Competence Networks||Pro-Net T3 - Tools, Targets, Therapeutics / Protein Competence Network Halle & Network of Excellence Saxony-Anhalt
InnoPlanta e.V. Gatersleben / Competence Networks Germany
Green Gate Gatersleben - The Plant Biotech Center
Center for Behavioral Brain Sciences (CBBS) Magdeburg / Network of Excellence Saxony-Anhalt
Chemical-Biotechnological Process Center Leuna / Fraunhofer Society
|Number of companies in the BioRegion||70|
Saxony-Anhalt as a location for Biotechnology and Biopharma consists of four different segments:
In the last years the Red Biotechnology develops into a profiling sector with a solid research basis and competitive R&D teams and rising companies.
Saxony-Anhalt has great technology transfer and translational potentials in the biopharmaceutical development and production and is developing from an attractive production site into an innovative R&D site for biopharmaceutical products and services.
The plant biotechnology is one of the most important biotechnology segments in Saxony-Anhalt with a longstanding tradition and an efficient research landscape.
The industrial use of renewable ressources has an increasing importance through the establishment of the Chemical-Biotechnological Process Center in Leuna developed by the Fraunhofer Gesellschaft.
||Dr. Klaus-Michael Weltring|
|R&D-Focus||Nanobioanalytics, Characterization of Nanomaterials in Biological Systems, Diagnostics,Iimaging, Environmental Analysis, Masspectrometry|
|Selected Regional /Thematic Clusters/Competence Networks||Center for Nanotechnology (CeNTech), European Institute for Molecular Imaging (EIMI)|
|Number of companies in the BioRegion||about 30
The association bioanalytik-muenster was founded in November 2000 as a regional network for researchers, companies and public organisations. It serves as the central communication and information platform for scientists, companies, investors and the public in the area of nanobioanalytics. Bioanalytik-muenster assists the concerted actions of all local players to develop the Münster region to a globally competitive nanobioanalytics location by
- boosting the competitiveness and innovation potential of the region in the area of nanobioanalytiks by targeted matching of the regional competence in academia and companies,
- raising funds for the advancement of the region,
- informing about the scientific and technological R&D results of the region.
|Bioregion||BIO CITY LEIPZIG|
|Location||Deutscher Platz 5, 04103 Leipzig, Germany|
|Contact Person||André Hofmann|
|Selected Regional /Thematic Clusters/Competence Networks||Regenerative Medicine; Industrial Enzymes; Cell Therapy|
|Number of companies in the BioRegion||26|
Factors for sustainable growth are a favourable structural and financial support and a network that has proven its value and works on an interdisciplinary basis. That’s exactly what makes BIO CITY LEIPZIG so unique. Here you can find everything that successful businesses may need.
|Contact Person||Dr. Heinz Bettmann|
|R&D-Focus||red and white Biotechnology|
|Selected Regional /Thematic Clusters/Competence Networks||BIO.NRW, DZNE German Centzer for Neurodegenerative Diseases, DLR German Aerospace Center, CECAD, BioRiver, CLIB 2021|
|Number of companies in the BioRegion||25|
BioCologne is an association to support biotechnology and life sciences in the cologne region. Members like biotech companies, academic and research institutions, investors and technology parks provide the transfer of new discoveries and technologies into startup companies. Both, existing companies and future entrepreneurs receive support with all questions ranging from setting-up and developing an enterprise. BioCologne communicates know how via MyBioCareer as well as financing solutions in cooperation with banks, investors or business angels.
The network offers various opportunities for synergies and supports special qualifications and the transfer of technology. International contacts allow worldwide contacts and cooperations. To ensure the future of biotechnology industry BioCologne provides development and marketing of the location cologne and communication between the biotech's as well.
|Contact Person||Lars Bauer|
|Selected Regional /Thematic Clusters/Competence Networks||Functional Genomics and Molekular Medicine (FunGene, HIKE, GANI_MED), Regenerative Medicine and Medical technologies (CELISCA Center for Life Science Automation, RESPONSE – Partnership for Innovation in Implant Technology, Campus PlasmaMed), Plant and Animal breeding (PHÄNOMICS, Bio-OK), Health economy (HIC@RE- Alliacne against MRSA|
|Number of companies in the BioRegion||120|
BioCon Valley is the initiative for Life Science and health economy of Mecklenburg-Vorpommern, Germany (www.bcv.org). As one of the German BioRegions BioCon Valley supports the commercial use of modern life sciences and bio- and medical technologies in the region. BioCon Valley´s tasks are networking, managing life science centers (bioincubators), project management and coordination, and life science specific public relation. BioCon Valley collaborates in strategic partnership to the life science initiatives at the Baltic Sea (www.scanbalt.org).
|Location||44799 Bochum / North Rine-Westphalia|
|Contact Person||Uwe Seidel|
|Selected Regional /Thematic Clusters/Competence Networks||-|
|Number of companies in the BioRegion||100|
The BioIndustry e. V. is a registered association which main purpose is to activate, to concentrate and to develop biotechnological competences in the Ruhr Region. As a networked service cluster of 55 companies, research and training institutes, technology centres, biotechnological service providers and communal business development organizations the association’s objective is to generate product- and process-innovations in biotechnology.
Our member´s competences cover the entire spectrum of biotechnology with focus on medical biotechnology, industrial biotechnology, AgriFood biotechnology, Bioinformatics and enabling technologies. Members are supported by service providers span all necessary management consulting and legal advisory services.
The regional decision-makers meet and exchange experience on a regular basis to support the active transfer from ideas to market. Members get assistance to find appropriate business partners, to develop and promote their projects and to acquire public funding.
|Bioregion||BioLAGO e.V. - life sciences in the international Lake Constance region|
|Contact Person||Michael Statnik|
|R&D-Focus||Pharma, Diagnostics, Biotechnology, Medical Engineering, Food, Environment Protection, Analytics, Medical and Bioinformatics|
|Selected Regional /Thematic Clusters/Competence Networks||Kompetenzzentrum Obstbau Bodensee, Center for Alternatives to Animal Testing Europe|
|Number of companies in the BioRegion||80 members (industry and research institutions)|
As a cross-border life science network BioLAGO e.V. unites closely cooperating companies and research institutions around Lake Constance in Germany, Switzerland, Austria and Liechtenstein. The organisation promotes knowledge and technology transfer between science and industry, the development of marketable services for and with members, supports science and technology education (public relations) as well as branding of the Lake Constance region as an international life science location.
|Bioregion||BioM / Munich Biotech Cluster|
|Location||Greater Munich Area|
|Contact Person||Prof. Dr. Horst Domdey|
|R&R-Focus||a) new therapeutics and diagnostics, personalized medicine
b) industrial Biotechnology
|Selected Regional /Thematic Clusters/Competence Network||Competence Region "personalized medicine"; Future Cluster of Excellence Initiative at LMU and TUM in protein, nano- and Neuro-Science; Competence Center of the national network of "Orphan Diseases"|
|Number of companies in the BioRegion||Biotech according to OECD: 85,
according to own census in "Pharmaceutics" 130 Active Biotech, 30 pharmaceutical, 50 CRO, 40 suppliers
Since winning the BioRegio Competition 1996, BioM is the coordination agency of the Munich Biotech Cluster and since 2006 additionally of the overall Bavarian biotechnology cluster. Since 2010, under the BioM management with the "Leading Edge Cluster m4" (BMBF Competition) a competency region for "personalized medicine" has been developed. The Munich region is characterized by internationally recognized scientific excellence, the basis is for the majority of spin-off companies. Most have been accompanied by BioM, from the first steps to a stable development. Today the BioM coordinated m4 Award is a regional validation support program (pre-seed) for the Bavarian life sciences.
|Contact Person||Bremerhaven Economic Development Company Ltd., Guido Ketschau|
|R&D Focus:||Biotechnology; Genomics/Proteomics; Molecular diagnostics and bioanalytics; Biomarker and diagnostics products for oncology and infections; personalized medicine; mobile Health; Mass spectrometry; Medical technology; Medical Image Computing; Nucleic acid analysis; Specialty chemicals for molecular biology; Food technology; Marine biotechnology; health economy;|
|Selected Regional /Thematic
|i³-Life Sciences Cluster North West; Society Gesundheitswirtschaft North West; Food industry, healt industry|
|Number of companies in the BioRegion||30|
The life sciences are key technologies to secure the future well-being of mankind and the environment.
Innovative life sciences companies are located in the region of Bremerhaven – Bremen. They are mainly focused on application- and market-oriented research in the area of analytics and diagnostics. The federal state of Bremen is providing many valuable and economic stimuli to life sciences area. The Bio Nord Biotechnology center Bremerhaven is an ideal environment to young and innovative research companies providing them with laboratories and infrastructure.
The newly initiated i³-Life Sciences Cluster North West is located at the Bio Nord center. It will focus and strengthen the competence of the sector. Identification and development of biomarker and modern analytic and diagnostic tools are on the focus.
|Bioregion||BIO.NRW Cluster Biotechnology North Rhine-Westphalia|
||40225 Düsseldorf, Merowingerplatz 1|
||Dr. Bernward Garthoff, Representative for Biotechnology of the German State of North Rhine-Westphalia|
|Selected Regional /Thematic
|Number of companies in the BioRegion||68
dedicated biotechnology companies focus
17 other biotechnologically active companies
Approx. 220 other life science related companies
North Rhine-Westphalia’s biotechnology cluster BIO.NRW is a central
catalyst for the sustainable development of the state’s biotechnology
It activates cooperation between business, research, investors, and policy-makers.
Our activities and services: Financing, Fairs and Exhibitions, Data&Analysis Biotech NRW, Marketing&PR, Promotion of young academics
|Bioregion||BIOPRO Baden-Württemberg GmbH|
||Dr. Barbara Jonischkeit|
|R&D-Focus||Interaction from Biotechnology, Pharmaceutical industry, Medical technology, Energy, Chemical industry and Environmental technology|
|Selected regional /Thematic Clusters/Competence Networks||Cluster Biopolymers/Biomaterials, Biomedical Technology Cluster ‘Medical Mountains’, Environmental Technology Network Baden-Württemberg, BioPharmaceutical Industry Network Baden-Württemberg, 5 BioRegions: BioRegion Rhine-Neckar-Triangle, Bioregion STERN, Bioregion Ulm, BioRegion Freiburg und BioLAGO|
|Number of companies in the BioRegion||-
As the state-wide service agency, BIOPRO Baden-Württemberg provides targeted support to research institutions and companies in the biotechnology and life sciences sectors.
As Baden-Württemberg’s central point of contact in the biotechnology and life sciences sectors, it is the task of BIOPRO Baden-Württemberg GmbH to optimally position the strengths of this leading biotechnology location on the national and international level at the same time as developing the location to ensure future sustainability. Specific business promotion measures help to secure know-how and jobs in the state as well as transferring the huge potential of innovative research to industrial applications. BIOPRO Baden-Württemberg GmbH's broad public relation work get people informed about this highly innovative cross-sectional technology.
|Location||BioPark Regensburg GmbH
||Dr. Thomas Diefenthal|
|R&D-Focus||Biotechnology, Medical Engineering, Pharma, Sensors|
|Selected Regional /Thematic Clusters/Competence Networks||The Interdisciplinary Agency IA-Biotech is the network linking technology in East Bavaria (interdisciplinary projects)
Strategic Partnership for Sensor Technologies, Optical Technologies in Photodynamics
|Number of companies in the BioRegion||42
The BioPark Regensburg GmbH is the management and administrative headquarters of the biotechnology research cluster known as BioRegio Regensburg in East Bavaria. Located strategically at the northernmost point of the Danube, in the Austrian-Czech-German triangle, the area is regarded as the gateway to the East of the extended European Union. Currently 42 firms with over 2500 employees are active in the field of life sciences in BioRegio Regensburg. As a result it has become the most important region for Biotechnology in Bavaria, second only to Munich.
|Bioregion||BioRegio STERN Management GmbH|
|Location||Stuttgart, Tübingen, Esslingen, Reutlingen und Neckar-Alb|
|Contact Person||Dr. Klaus Eichenberg|
engineering & automation
|Selected Regional /Thematic
|Competence network medtech & biotech, health region of the future "REGiNA - regenerative medicine in the area between Stuttgart, Tübingen and Neckar-Alb, clusterinitiative ELSA "engineering-life sciences-automation|
|Number of companies in the
|ca.100 biotechnology companies
ca. 120 medtech companies
BioRegio STERN Management GmbH is since 2001 a skill-sharing network, providing a help and advice centre for founders of new businesses, entrepreneurs and researchers in the life sciences sector in the cities of Stuttgart, Tübingen, Esslingen and Reutlingen and the Stuttgart and Neckar-Alb regions. As cross-technology network we promote cooperations between different disciplines such as biotechnology, medical technology, sensor technology, biochemical analysis, diagnostics, bioinformatics and automation technology. BioRegio STERN Management GmbH represents the interests of these market players in dealings with political circles, the media and associations and provides advice on grant applications and corporate financing. Key focal points include regenerative medicine, medical technology and the automation of biotechnology.
|Contact Person||Dr. Maike Rochon|
|R&D-Focus||neuroscience, stem cell biology and regenerative medicine, translational medicine, molecular diagnostics, biotechnology, refining of carbohydrates, implantology, audiology, biophotonics|
Selected Regional /Thematic Clusters/Competence Networks
Hannover, Braunschweig, Göttingen, Oldenburg, Wilhelmshaven, Cuxhaven
Thematic competence networks:
Biomedical Technology and Regenerative, Medicine (BiomeTI e.V., NZ-BMT, REBIRTH, SFB 599, Transregio 37), Infection Research and Translational, Medicine (TRAIN), DFG Research Center Molecular, Physiology of the Brain, Audiology (AIN)
Number of companies in the BioRegion
BioRegioN is the network initiative for life sciences in Lower Saxony. We connect partners from the worlds of business, science and politics with the main goal to bring the tremendous potential for excellent research results effectively to the market.
Our activities focus on supporting and advising regional companies, universities and research institutions in the fields of biotechnology, regenerative medicine and biomedical technology. We provide up-to-date information on trends and developments in the life sciences sector, as well as on funding and cooperation opportunities for our network partners. We also initiate innovative research and development projects at EU-, federal- and state level.
||Dr. Gabriele Gröger|
|R&D-Focus||Development and production of biopharmaceuticals; cellular differentiation, regenerative medicine|
|Selected Regional /Thematic Clusters/Competence Networks||BioPharMaXX Cluster; Comprehensive Cancer Center Ulm|
|Number of companies in the BioRegion||
The BioRegionUlm is a biopharmaceutical site with international standing. Between Ulm and Lake of Constance an outstanding and long established experience has been focussed on the development and production of biopharmaceuticals particularly with mammalian cell culture, including the fill and finishing. Covering the complete biopharmaceutical value chain the BioRegionUlm’s biotech competence is therefore of international dimension.
|Dr. Christian Andersen, Dr. Gerhard Frank|
|R&D-Focus||Infection biology; nanobiotechnology; biotechnology; microbiology; immunology; biomedical research|
|Selected Regional /Thematic Clusters/Competence Networks||Innovation and Entrepreneur Center Wuerzburg (IGZ); University of Wuerzburg; Fraunhofer ISC|
|Number of companies in the BioRegion||60|
The Innovation and Entrepreneur Center (IGZ) in Wuerzburg represents one of the major biotech clusters in the Free State of Bavaria. Main topics in this bioregion are biotechnology and biomedicine , medical technology and nanotechnology. The bioregion and the IGZ are located at the Science Park in Wuerzburg, an area of 70,000 square meters reserved for the settlement of high-tech companies and service providers located in the east of Wuerzburg. Here, some 2,500 square meters of laboratory space with adequate technical infrastructure, and about 3,000 square meters of office space are available for high-tech companies. The bioregion benefits from its proximity to the university and university hospital, the university of applied sciences, and numerous research facilities.
|Bioregion||BioRiver – Life Science im Rheinland e.V.|
|Contact Person||Dr. Frauke Hangen|
|R&D-Focus||Diagnostics/Analytics, Pharmacological research, Drug development, Enzyme Technology, Aging associated deseases, Plant breeding and science, Medical Technology|
|Selected Regional /Thematic Clusters/Competence Networks||CLIB2021 – Cluster for Industrial Biotechnology, HealthRegion Cologne Bonn|
|Number of companies in the BioRegion||208 life science companies, about120 biotech companies|
History: Since 2004 BioRiver is the active network organisation for the life science industry in the Rhine region between Düsseldorf, Cologne, Bonn and Aachen. Independent from public funding, the initiative is financed by its members.
Objectives: BioRiver catalyses intensive knowledge transfer between academic research and companies and sees to an additional marketing for the members and the region. Furthermore the organisation successfully aims to improve the political awareness and financial general conditions.
Actions: Besides network activities, meetings and information BioRiver realises the BIO.NRW.academy by the order of BIO.NRW. Many of the BioRiver projects stand out by their making in cooperation with local, regional or other partners.
|Bioregion||BioRN Network e. V.|
|Contact Person||Dr. Friedrich Richter|
|R&D-Focus||Drug discovery and development particularly in the areas of cell-based and molecular biology; cancer research; biomarker discovery; targeted therapeutics and diagnostics development; personalized medicine|
|Selected Regional /Thematic Clusters/Competence Networks||Regional cluster:
Biotech Cluster Rhein-Neckar (BioRN), Rhine-Neckar Metropolitan Region (Heidelberg, Mannheim, Ludwigshafen)
Thematic competence network:
Bernstein Centre for Computational Neuroscience, Bioquant / Viroquant: Model Base of Life, Excellence Cluster on Cellular Networks, Office National Genome Research Network (NGFN plus), Heart Centre Heidelberg, HIRO: National Center for Radiation Research in Oncology Dresden / Heidelberg, Helmholtz Alliance on Immune Therapy of Cancer, Helmholtz Alliance System Biology of Signaling in Cancer, Interdisciplinary Center for Neurosciences (IZN), International Cancer Genome Consortium (ICGC), Leading-Edge Cluster “Cell-based and molecular medicine”, Medical System Biology of Chronic Wounds Molecular Medicine Partnership Unit (MMPU), National Center for Tumor Diseases (NCT) Heidelberg, ZMBH DKFZ Alliance
|Number of companies in the BioRegion||Approx. 80 biotechnology/ pharmaceutical companies
Approx. 30 supplier to biotechnology
BioRN Network association consists of a network of about 80 science and industry partners. It promotes the development of the Rhine Neckar reBioRN Network association consists of a network of about 80 science and industry partners. It promotes the development of the Rhine Neckar region into one of the leading life-science clusters in Europe.
Network members are internationally renowned research institutions such as the University of Heidelberg, the Mannheim University of Applied Sciences, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL), six global pharmaceutical companies (AbbVie, Boehringer Ingelheim, J&J, Merck, Roche and Sanofi) as well as small and medium-sized life science companies and local public organizations.
BioRN Cluster Management GmbH is a public-private partnership between the BioRN Network and Heidelberg Technology Park charged with the coordination, networking, marketing and development of the BioRN cluster.
In 2011 BioRN was founding member of the Health Axis Europe (HAE) alliance with the bio-medicine clusters of Cambridge (UK), Leuven (Belgium), Maastricht (NL) and Copenhagen (DK). Its main goal is the empowering of innovative forces to strengthen the international competitiveness as well as the creation and coordination of joint projects across Europe.
|R&D-Focus||regenerative medicine/therapy, molecular bioengineering, diagnostics, nano-biotechnology, industrial biotechnology|
|Selected Regional /Thematic Clusters/Competence Networks:||BioInnovationsZentrum Dresden, BIO CITY Leipzig, CRTD (DFG Research Center for Regenerative Therapies in Dresden), TRM Leipzig (Translational Center of Regenerative Medicine), Biotechnological–biomedical centre of the University of Leipzig, Biotechnological Centre (BIOTEC) of the Technical University of Dresden|
|Number of companies in the BioRegion||47 Core Biotechs, 65 Core Biotechs plus biotech-related businesses, 80 with pharma businesses|
biosaxony e.V. is a registered association representing biotechnology and related areas from materials science to medical equipment throughout the German region of Saxony. The members represent the various life science companies, research centers and representatives of the sector in Saxony. The aims of biosaxony e.V. are to initiate projects between industry and science, to network services and expertise, and to leverage synergies to boost the development of the biotech industry and publicize the region’s expertise
|Bioregion||Ci3 Cluster für Individualisierte Immunintervention e. V. (Ci3)|
|Location||Metropolitan area Rhine-Main|
|Contact Person||Dr. Andrea Schilz|
|R&D-Focus||Development of stratified and individualized immunotherapies, biomarker and diagnostic products in indications like cancer, autoimmune diseases and infections.
Vaccine, Antibodies, RNA Therapeutics, Adoptive Cell Therapies, Bioinformatic
|Selected Regional /Thematic Clusters/Competence Networks||CIMT Cancer Immunotherapy Consortium, Fraunhofer ICT-IMM, Georg-Speyer-Haus, Loewe Center for Cell and Gene Therapy Frankfurt, MPI for Polymer Research, Paul ehrlich Institute, TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, Leading-Edge Cluster Ci3|
|Number of companies in the BioRegion||approx. 90|
The Cluster for Individualized ImmuneIntervention (Ci3) bundles the outstanding expertise in the Rhine-Main cluster region in the area of biotechnology-based individualized medicine focusing on immune therapies and diagnostics. Ci3 is the integrative element across the entire value chain, from early innovation to production, marketing and application, and connects more than 120 stakeholders from industry, research, medical care providers and politics. Supported by the German Federal Ministry of Education and Research (BMBF), through currently more than 25 R&D projects Ci3 katalysis the development of new efficient immune interventions for stratified and individualised markets in the field of cancer, autoimmune and infectious diseases.
|Bioregion||Freiburg / BioValley|
|Location||Upper Rhine region in the border triangle of Germany, France and Switzerland|
||Dr. Michael Richter|
|R&D-Focus||Plant Biotechnology, Tissue Engineering, Oncology, Immunology, Molecular, Biology / Molecular Medicine, Neurosciences, Biomimetic, Nanotechnology, Systems Biology, Material Sciences|
|Selected Regional /Thematic Clusters/Competence Networks||Regional cluster:
Partner of trinational BioValley
Thematic competence networks:
Neuroscience Upper Rhine Network (neurex), Bernstein Center for Computational Neuroscience Freiburg (bccn), Centre for Biochemistry and Molecular Cell Research (ZBMZ), Center for Biological Systems Analysis (ZBSA), Competence Network Biomimetics Freiburg, Excellence Cluster “Center of Biological Signalling Studies” (bioss)
|Number of companies in the BioRegion||The Upper Rhine is a globally unique cross-border life sciences cluster with one of the highest densities of activities involving life sciences in the world with approx. 600 companies (including 40% of the biggest pharmaceuticals companies in the world).|
Freiburg BioRegion, an attractive and dynamic region offering a high quality of life, is located in Germany but is close to both France and Switzerland. It is a partner of the trinational BioValley – Life Sciences and Medical Technologies Cluster which combines the biotechnological potential of the centres in Freiburg (D), Basle (CH) and Strasbourg (F).
|Bioregion||HealthCapital Berlin Brandenburg, Cluster Life Sciences / Healthcare Industries|
|Ansprechpartner:||Dr. Kai Bindseil, Cluster Manager Life Sciences / Healthcare Industries|
|F&E-Fokus||active ingredient development, molecular diagnostics and bioanalytics, regenerative medicine, proteomic and genomic research, and some fields of industrial biotechnology|
|Ausgewählte Regionale und
thematische Cluster/ Kompetenz-Zentren:
|Regenerative Medicine Initiative Berlin; Center for Molecular Diagnostics and Bioanalytics (ZMDB); DiagnostikNet-BBNutriAct; Network for Drug Discovery & Development Berlin-Brandenburg (NetDDD); RiNA RNA-Network; Berlin-Brandenburg Center for Regenerative Therapies BCRT; NeuroCure Cluster of Excellence Berlin|
|Anzahl der Unternehmen in der BioRegion||230 biotech companies, 30 pharmaceutical companies|
The Berlin-Brandenburg region is one of the leading life sciences and healthcare industries centers in the world. The region’s main strengths are its unique concentration of science, clinics and business and the close network they maintain. Numerous technology parks and networks in different fields, above all biotechnology and medical technology, create an ideal infrastructure for transforming the latest scientific findings into innovative products for the healthcare sector. HealthCapital is the central contact and coordination office for all issues concerning biotechnology in the German capital region.
|Contact Person||Dr. Janin Sameith|
|R&D-Focus||drug development (from basic research, preclinical, and scale-up to manufacturing)
areas of major importance:
metabolism, inflammation, pain, oncology, central nervous system
Development and production of vaccines, industrial biotechnology, especially in applications in fine and specialty chemistry medical technoloogy
|Selected Regional /Thematic Clusters/Competence Networks||Regional cluster:
Central Hessen Region (Marburg, Gießen); vaccines, plasma products, diagnostics, Southern Hessen (Frankfurt, Darmstadt); pharmaceutical R&D, industrial biotechnology
Thematic competence network:
CIB Cluster Integrated Bioindustry Frankfurt: industrial biotechnology, TIMM: Technologie und Innovation – Medizinregion Mittelhessen
|Number of companies in the BioRegion||225|
As a leading Biotechnology Center in Europe, Hessen offers unsurpassed opportunities for the biotechnology industry – a concentrated network of higher education and research institutes combined with a vast pool of highly qualified life sciences personnel.
In order to promote the biotechnology industry, the Hessian Ministry for the Economy has established “Hessen-Biotech” as a central coordination point.
- Offers up-to-date industry information (studies, “Hessen-Biotech NEWS” and Hessen’s online biotech industry directory “Competence Atlas Hessen-Biotech”.
- Connects and advises biotechnology companies: Facilitate information exchange between Hessen’s companies, colleges, universities and research institutions.
- Is a communication platform: Organizing cooperative booths at international trade fairs as well as symposiums, workshops and congresses on current biotechnology discussion topics.
Hessen-Biotech is administered and managed by the Hessen Trade & Invest GmbH in Wiesbaden.
|Bioregion||Thuringia (InfectoGnostics Forschungscampus Jena e.V.)|
|Contact Person||Jens Hellwage, PhD|
|R&D-Focus||infectious diseases, Optics, Diagnostics|
|Selected Regional /Thematic Clusters/Competence Networks||InfectoGnostics Research Campus, Optonet, TGZ Gera, Medways|
|Number of companies in the BioRegion||110 companies in Life Sciences with approx. 300 suppliers|
The InfectoGnostics research campus is a public-private partnership developing new methods in infection diagnostics. In a triad of technology, application and production, more than 30 partners from science, medicine and industry are developing marketable solutions for rapid and cost-effective on-site analysis (point-of-care testing) of infections in human medicine, animal diseases, and pathogen detection in food.
In Thuringia there are approx. 60 biotech companies (manufacturers and service suppliers) with a company focus mainly on medical and pharmaceutical applications. With about 50 medical technology companies and 300 suppliers, the medical technology sector is one of the most innovative in Thuringia. The field is deeply rooted in traditional industries such as optics, precision engineering and pharmaceutical industries. The interdisciplinary orientation of the Thuringian research landscape provides a good foundation for R&D activities in the field of Life Sciences. Universities, research institutes, and clinics are available to collaborate with corporate partners.
|Bioregion||Life Science Nord|
|Location||Hamburg and Schleswig-Holstein|
|Contact Person||Dr. Hinrich Habeck (Managing Director)
Dr. Thomas Frahm
|R&D-Focus||Biotechnology, Medical Technology, Pharmaceutics|
|Selected Regional /Thematic Clusters/Competence Networks||Molecular Imaging: Magnetic Particle Imaging (MPI), Molecular Imaging Center North (MOIN CC), Universität zu Lübeck, UKE
Drug Screening: Fraunhofer IME Screeningport, NEU2, DESY
Infection and hygiene: University Medical Center Hamburg-Eppendorf (UKE), Universitätsklinikum Schleswig-Holstein (UKSH), Bernhard Nocht Institute for Tropical Medicine (BNI), Heinrich Pette Institute for Experimental
Virology and Immunology (HPI), Centre for Structural Systems Biology (CSSB) German Center for Infection Research Borstel, Exzellenzcluster Inflammation at Interfaces
Knochenheilung: UKSH, UKE, CAU, Berufsgenossenschaftliches Unfallkrankenhaus BUK Boberg, Technische Universität Hamburg-Harburg (TUHH)
Marine Biotechnologie: Fraunhofer- Einrichtung für Marine Biotechnologie (EMB), Kieler Wirkstoff Zentrum (KIWIZ)
Industrielle Zelltechnologie (Industrial Cell Technology)
Industrielle Biotechnologie Nord (IBN),
Center for Applied Nanotechnology (CAN)
|Number of companies in the BioRegion||about 500|
The two North German states of Schleswig-Holstein and Hamburg stand out for their broad base of companies and for the presence of a complete value chain in the life sciences.
Under the umbrella of Life Science Nord, the cluster agency Life Science Nord Management GmbH and the Life Science North e.V. association work together towards the goal of further developing the Hamburg and Schleswig-Holstein region into an internationally leading Life Science Network.
For this purpose, roughly 200 companies and research institutes have organised themselves as active members and advocates of Life Science Nord e.V. The association bundles the common positions and interests of these players in the biomedical sciences and the medical technology and biotechnology / pharmaceutical industries. As an additional benefit, the association offers its supporting members a partner programme in cooperation with the cluster management.
The cluster organization Life Science Nord Management GmbH initiates strategic projects and supports the promotion of companies, science and institutes with an emphasis on innovative medicine. As a cluster management, it connects business and research in the north, thereby bringing to companies the expertise from universities and research facilities as well as its network of close contacts. Additionally, the management is responsible for representing the regional life sciences on national and international levels. Life Science Nord is represented in the Council of German BioRegions by Life Science Nord Management GmbH, TuTech Innovation GmbH and WTSH Business Development and Technology Transfer Corporation of Schleswig-Holstein.
|Ansprechpartner:||Carin Jansen, PhD|
|F&E-Fokus||Biotechnology, Medical Engineering, Pharmacology, Bio-economy, Tissue Engineering, Analytics, Synthetic Biology|
|Ausgewählte Regionale und thematische Cluster/Kompetenz-Zentren:||Aachener Kompetenzzentrum Medizintechnik (AKM), innovating medical technology (in.nrw), Forschungszentrum Jülich|
|Anzahl der Unternehmen in der BioRegion||42|
|Bioregion||NanoBioNet e. V.|
|Contact Person||Cathrin Pauly|
|R&D-Focus||nanochemistry, nanobiotechnology, new materials, pharmaceutical biotechnology, medical biotechnology, cryotechnology/cellbanking|
|Selected Regional /Thematic Clusters/Competence Networks||SSaarbrücken, St. Ingbert, Homburg, Kaiserlautern, Wendelsheim, Mainz|
|Number of companies in the BioRegion||23|
cc-NanoBioNet is a network connecting universities, research institutes, hospitals, and companies. The non-profit association was founded to enhance the communication between research, economy, politics and the public. Our goal is to:
- create new, innovative, and marketable products and workplaces,
- create and provide nanobiotechnological teaching contents for all education levels,
- support research and development
- inform the public about the exciting world of nanobiotechnology.
Our key issues are
- chemical nanotechnology
- pharmaceutical biotechnology and
- nanoethics and nanosafety
|Bioregion||Technologiepark Heidelberg GmbH|
|Contact Person||Dr. André H.R. Domin|
|R&D Focus||Biotechnology, Pharma, organic electronics, environmental technology, printed electronics and IT|
|Selected Regional/Thematic Clusters/Competence Networks||BMBF Spitzencluster Forum Organic Electronics im Heidelberger InnovationLab
BioRN Cluster Management GmbH
BioRN Network e.V.
BIO Deutschland, Berlin
Bundesverband Deutscher Innovations-, Technologie- und Gründerzentren e. V. (BVIZ), Berlin
Gesellschaft internationaler Wissenschaftsparks (IASP), Malaga, Spanien
Organisation der Biotechnologie-Industrie (BIO), Washington DC, USA
|Number of companies in the BioRegion||With an area of 80,000 m² and more than 90 companies and research facilities, the Heidelberg Technology Park is one of the most important biotechnology locations in Germany and one of the world's leading biotechnology centers.|
The Techologiepark Heidelberg was founded in 1984 as the first science park in Germany with a life science focus. Through its growth in the fields of biotechnology, pharmatechnology, environmental technology, printed electronics, as well as IT, it has been able to expand into five locations. The Technologiepark supports the exchange between research and industry and spin-offs from science with the necessary infrastructure. By working closely with internationally active partners, it offers local businesses a large network. A further location, the 7000 m² Business Development Center Organic Electronics, will be opened in the Heidelberg Innovation Park in the middle of 2019.